XTL BIOPHARMACEUTICALS LTD — Form D
XTL BIOPHARMACEUTICALS LTD of RAANANA, L3, a company, filed a Form D exempt-offering notice with the SEC on 2017-03-29. The offering totals $2.8M, of which $2.8M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2017-03-29
- Form: D
- Accession: 0001144204-17-017314
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $2.8M
- Amount sold: $2.8M
- Investors: 22
- Date of first sale: 2017-03-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-283590
Issuer
- Name: XTL BIOPHARMACEUTICALS LTD
- CIK: 0001023549
- Entity type: Corporation
- Jurisdiction: ISRAEL
- Address: 5 HACHAROSHET ST., RAANANA, L3, 4365603
- Phone: 972 9 955 7080
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| David Hillel Bassa | Director | Raanana, L3 |
| Ossi Hillel Fain | Director | Raanana, L3 |
| Dobroslav Hillel Melamed | Director | Raanana, L3 |
| Oded Hillel Nagar | Director | Raanana, L3 |
| Jonathan Hillel Schapiro | Director | Raanana, L3 |
| Shlomo Shalev | Director | Petah Tikvah, L3 |
| Doron Hillel Turgeman | Director | Raanana, L3 |
| David Hillel Kestenbaum | Executive Officer | Raanana, L3 |
| Joshua Hillel Levine | Executive Officer | Raanana, L3 |
Other filings by this issuer (1)
More